On September 3, INSILICO rose 5.16% in regular trading, trading at 47.3 HKD/share, with turnover of approximately 96.24 million HKD, extending its recent upward trajectory.
On the news front, the stock was officially added to the MSCI Global Small Cap Indexes after the market close on August 31, and passive tracking fund allocation demand continues to flow in. Institutional positioning has strengthened notably, with Hong Kong Stock Connect cumulative holdings climbing from 5.92% in late June to 25.09%, while JPMorgan raised its stake to 5.56% after purchasing approximately 4.29 million shares at an average price of 43.42 HKD on August 20.
Fundamentally, the company reported H1 revenue of USD 106 million, up 287.2% year-over-year, achieving its first half-year profit since listing with net income of USD 35.5 million, versus a loss of USD 19.2 million in the prior-year period. Adjusted net profit reached USD 51.2 million, with gross margin improving to 90.3%. Drug discovery and pipeline development revenue of approximately USD 103 million, up 331.3%, served as the primary revenue contributor.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments